A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone
Clinical trial NCT00525330 · COMPLETED
Trial details
- NCT number
- NCT00525330
- Sponsor
- ActivX Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-08-01
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.